Inotiv, Inc. — Director's Dealing 2019

Jan 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-01-14

Reporting Person: Leasure Robert Jr. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-14	Common Shares	A	34615	—	Acquired	60715	Direct
2019-01-14	Common Shares	A	10000	—	Acquired	70715	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-14	Employee Stock Option (right to buy)	$1.30	A	55000	Acquired	2029-01-14	Common Shares (55000)	Direct

Footnotes

F1: Represents restricted grant subject to vesting and forfeiture.

F2: The option becomes exercisable with respect to 18,334 shares on the first anniversary of the date of grant and with respect to an additional 18,333 shares on each of the second anniversary and the third anniversary of the date of grant, respectively.